첨단 상처 치료 시장 - 세계 산업 규모, 점유율, 동향, 기회 및 예측 : 제품별, 용도별, 최종 사용자별, 지역별, 경쟁(2021-2031년)

The Global Advanced Wound Care Market is projected to expand from USD 11.29 Billion in 2025 to USD 15.15 Billion by 2031, demonstrating a Compound Annual Growth Rate (CAGR) of 5.02%. This market encompasses specialized therapeutic products, such as hydrocolloids, alginates, and negative pressure wound therapy devices, which are specifically designed to treat complex acute and chronic wounds by fostering an optimal moist healing environment. A primary catalyst for this market's growth is the increasing worldwide prevalence of chronic lifestyle diseases, particularly diabetes, which significantly contributes to the incidence of ulcers that are difficult to heal. As reported by the International Diabetes Federation, approximately 589 million adults globally were living with diabetes in 2025, thereby creating a substantial and expanding patient demographic that requires effective, long-term wound management solutions. Despite the strong demand, the market faces a considerable hurdle due to the elevated cost of these advanced therapies compared to conventional dressings. This financial constraint is often intensified by restrictive reimbursement policies in developing regions, which consequently limit patient access to these crucial treatments. Such limitations often compel healthcare providers to opt for less effective, lower-cost alternatives, ultimately hindering the broader expansion of the market.

Market Driver

The escalating global geriatric population stands as a principal driver for market expansion, fundamentally transforming the demand for therapeutic solutions. As individuals age, physiological changes like diminished skin elasticity, impaired vascular function, and slower cellular regeneration substantially heighten their susceptibility to chronic conditions such as venous leg ulcers and pressure injuries. This demographic shift necessitates a move away from traditional dressings towards active therapies capable of managing exudate and promoting tissue repair in compromised patients. According to the World Health Organization's February 2025 'Ageing: Global population' report, the number of people aged 60 and older worldwide is anticipated to reach 1.4 billion by 2030, highlighting an urgent need for scalable, long-term wound management strategies that address the complexities of aging skin. Concurrently, technological advancements in wound care products are instrumental in driving market growth, particularly through the development of biologics and cellular tissue products. Innovations like fish-skin grafts and bioactive dressings are increasingly favored for their capacity to accelerate closure in stubborn wounds where conventional treatments have failed. The rapid adoption of these sophisticated technologies is underscored by recent industry performance; for example, Coloplast A/S's November 2025 'Annual Report 2024/25' indicated that its Kerecis wound and tissue repair segment achieved a 20% growth rate, reflecting the swift market acceptance of lipid-rich biologic solutions. This specific demand for enhanced efficacy bolsters the sector's resilience, as further demonstrated by Convatec Group Plc, whose February 2025 'Annual Report and Accounts 2024' reported an Advanced Wound Care revenue increase of 6.8% to $743 million, signifying the sustained commercial momentum of these high-tech interventions.

Market Challenge

The substantial cost of specialized therapeutic products presents a primary impediment to the growth of the Global Advanced Wound Care Market. Advanced solutions, including negative pressure wound therapy and bioactive dressings, are considerably more expensive than traditional wound management options. This significant price difference creates a major financial barrier, especially in healthcare systems with limited budgets. Consequently, payers and insurance providers frequently implement stringent reimbursement policies to manage expenditures, which restricts healthcare providers' ability to prescribe these effective yet costly treatments. When reimbursement is either denied or capped, clinicians are often forced to use more affordable, but less effective, alternatives, directly reducing the adoption rates and revenue potential for manufacturers of advanced wound care products. The extent of this financial burden is clearly illustrated by recent data detailing the economic impact of wound management. According to Advances in Wound Care, the official journal of the Wound Healing Society, the estimated annual cost of treating chronic wounds within the U.S. Medicare system alone reached $22.5 billion in 2025. This immense aggregate cost motivates payers to enforce rigorous coverage limitations and strict payment criteria. As reimbursement pathways become narrower to mitigate these escalating expenditures, the commercial reach of advanced wound care products is effectively constrained, thereby hindering broader market growth.

Market Trends

The widespread adoption of wearable and portable negative pressure wound therapy (NPWT) devices is fundamentally transforming the market by enabling a crucial shift from inpatient facilities to home-based care. These compact, often single-use, and canister-free systems allow patients to maintain mobility while undergoing continuous therapy, effectively addressing the need for cost-efficient outpatient solutions that reduce hospital stays. This technological evolution toward patient-centric designs is generating substantial commercial traction, particularly as healthcare systems increasingly prioritize remote management capabilities. Strong evidence for this trend is found in recent financial results; according to Smith+Nephew's February 2025 'Fourth Quarter and Full Year 2024 Results', the company's Advanced Wound Devices segment reported an underlying revenue growth of 20.6%, largely driven by the accelerated uptake of its PICO single-use negative pressure system. In parallel, the sector is demonstrating a significant focus on sustainable and eco-friendly wound care materials, prompted by escalating regulatory pressures and institutional demand to reduce the environmental impact of medical waste. Manufacturers are proactively redesigning product lifecycles to incorporate renewable inputs and minimize reliance on plastics, thus transitioning sustainability from a mere corporate responsibility metric into a key competitive differentiator. This strategic alignment with green manufacturing principles is correlating with positive financial outcomes for leading industry players. For instance, Molnlycke Health Care's April 2025 'Annual report 2024' indicated a net sales increase of 7.4%, a growth rate bolstered by its strategic investments in sustainable healthcare solutions and decarbonized operational processes.

Key Market Players

• Convatec Group PLC
• Molnlycke AB
• B. Braun SE
• 3M Company
• Urgo Group
• Coloplast Corp
• Integra LifeSciences Corporation
• Medline Industries, LP.
• Boston Scientific Corporation

Report Scope

In this report, the Global Advanced Wound Care Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Advanced Wound Care Market, By Product

• Moist
• Antimicrobial
• Active

Advanced Wound Care Market, By Application

• Chronic Wounds
• Acute Wounds

Advanced Wound Care Market, By End User

• Hospitals
• Specialty Clinics
• Home Healthcare
• Others

Advanced Wound Care Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Advanced Wound Care Market.

Available Customizations:

Global Advanced Wound Care Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Advanced Wound Care Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Moist, Antimicrobial, Active)
  • 5.2.2. By Application (Chronic Wounds, Acute Wounds)
  • 5.2.3. By End User (Hospitals, Specialty Clinics, Home Healthcare, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Advanced Wound Care Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Application
  • 6.2.3. By End User
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Advanced Wound Care Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By End User
  • 6.3.2. Canada Advanced Wound Care Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By End User
  • 6.3.3. Mexico Advanced Wound Care Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By End User

7. Europe Advanced Wound Care Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Application
  • 7.2.3. By End User
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Advanced Wound Care Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By End User
  • 7.3.2. France Advanced Wound Care Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By End User
  • 7.3.3. United Kingdom Advanced Wound Care Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By End User
  • 7.3.4. Italy Advanced Wound Care Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By End User
  • 7.3.5. Spain Advanced Wound Care Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By End User

8. Asia Pacific Advanced Wound Care Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Application
  • 8.2.3. By End User
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Advanced Wound Care Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By End User
  • 8.3.2. India Advanced Wound Care Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By End User
  • 8.3.3. Japan Advanced Wound Care Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By End User
  • 8.3.4. South Korea Advanced Wound Care Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By End User
  • 8.3.5. Australia Advanced Wound Care Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By End User

9. Middle East & Africa Advanced Wound Care Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Application
  • 9.2.3. By End User
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Advanced Wound Care Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By End User
  • 9.3.2. UAE Advanced Wound Care Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By End User
  • 9.3.3. South Africa Advanced Wound Care Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By End User

10. South America Advanced Wound Care Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Application
  • 10.2.3. By End User
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Advanced Wound Care Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By End User
  • 10.3.2. Colombia Advanced Wound Care Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By End User
  • 10.3.3. Argentina Advanced Wound Care Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Advanced Wound Care Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Convatec Group PLC
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Molnlycke AB
• 15.3. B. Braun SE
• 15.4. 3M Company
• 15.5. Urgo Group
• 15.6. Coloplast Corp
• 15.7. Integra LifeSciences Corporation
• 15.8. Medline Industries, LP.
• 15.9. Boston Scientific Corporation

16. Strategic Recommendations

17. About Us & Disclaimer